Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07389967 · ClinicalTrials.gov registry record · NA

Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

A NA study of Breast Cancer and Breast Cancer Metastatic, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT07389967: Recruiting NA study of Breast Cancer and Breast Cancer Metastatic, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT07389967 is a NA study of Breast Cancer and Breast Cancer Metastatic that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 200 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07389967, a NA study of Breast Cancer and Breast Cancer Metastatic, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This study explores perspectives of women with non-metastatic breast cancer regarding their willingness and ability to make dietary changes pertaining to foods/food products that may pose a risk to their cancer prognosis and survival. This is a single-group study conducted entirely online. All study activities, including consent, educational brochure and surveys, will be completed remotely. Participants will receive email invitations to complete questionnaires in REDCap. Questionnaire 1 will collect sociodemographic information (no PHI) and a brief dietary recall. Questionnaire 2 will assess identification of ultra-processed foods. Before Questionnaire 3, participants will review a two-page educational flyer explaining the link between diet, obesity, and cancer, with information on unhealthy calories and food processing. Questionnaire 3 will assess participants' willingness and ability to eat healthier foods and reduce unhealthy foods. At study completion, participants will receive a thank-you message and a brief satisfaction survey.

Primary Outcome

the perspectives of women with non-metastatic breast cancer on their willingness and ability to make dietary changes related to specific foods and food products will be assessed. Responses will be collected using a patient-reported questionnaire with a 5-point Likert scale ranging from "Unwilling" to "Very Willing" and "Unable" to "Very Able." Higher scores indicate greater willingness and ability to make healthier dietary choices.

Interventions

  • BEHAVIORAL Educational Brochure

Study Locations (1)

North Carolina

  • UNC Cancer Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2026-01-20
Est. Completion 2027-01
Phase NA

What NCT07389967 shows while recruiting

NCT07389967 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Educational Brochure is the first listed.

NCT07389967 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07389967 about?

NCT07389967 is a clinical study titled "Nutrition Awareness Among Women With Non-Metastatic Breast Cancer". This study explores perspectives of women with non-metastatic breast cancer regarding their willingness and ability to make dietary changes pertaining to foods/food products that may pose a risk to their cancer prognosis and survival. This is a single-group study conducted entirely online. All stud...

What is the current status of trial NCT07389967?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2026-01-20. Estimated completion is 2027-01.

What conditions does trial NCT07389967 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Metastatic.

What interventions are being tested in trial NCT07389967?

The interventions under investigation include: Educational Brochure (BEHAVIORAL).

Who is sponsoring clinical trial NCT07389967?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07389967 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07389967's enrollment target sits among peer trials

200 362nd of 1224 higher than 841 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07389967, the US trial registry maintained by the National Library of Medicine. NCT07389967 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.